Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Amino acid PET catches a spectrum of pediatric malignancies

Cancer screening with amino acid PET has already been validated for adults, but it has now been deemed a powerful tool for tumor localization in children and young adults, according to a study published Sept. 19 in the Journal of Nuclear Medicine.

Anatomical biomarker is missing link in Parkinson’s progression

Visualization of Parkinson’s disease (PD) development may now be possible by identifying dopaminergic nigrosomes, or the lack thereof, according to a study published Aug. 6 in Neurology

WMIC 2013 focuses on first-in-human studies and new scientists

The 2013 World Molecular Imaging Congress (WMIC) held Sept. 18-21 in Savannah, Ga., highlighted biomarker clinical trials, diabetes and brain research, advances in technology and a program that encouraged emerging experts, say World Molecular Imaging Society leaders in an exclusive interview with Molecular Imaging.

Siemens’ PETNET Solutions to provide PET radiopharmaceutical services for the US Oncology Network

Siemens’ PETNET Solutions has announced a three-year agreement with The US Oncology Network to supply its entire portfolio of Food and Drug Administration (FDA)-approved PET radiopharmaceutical agents at each of PETNET Solutions’ current Good Manufacturing Practices (cGMP)-certified locations throughout the United States.

Thumbnail

Double duty: Cancer therapy moonlights as breast tumor imaging agent

Metastatic breast cancers positive for HER2 receptor expression can be effectively imaged with Cu-64 DOTA-trastuzumab, traditionally used as a therapeutic drug, according to a study published online Sept. 12 in the Journal of Nuclear Medicine.

WMIC brings the world of molecular imaging to Georgia this week

The World Molecular Imaging Congress being held in Savannah, Ga., from September 18 – 21 is in full swing and bringing new focus to the worldwide molecular imaging agenda.

Definiens and Advanced Cell Diagnostics launch software for quantitative RNA in situ hybridization

Definiens AG, a healthcare company that advances personalized medicine through image analysis and digital pathology solutions, and Advanced Cell Diagnostics (ACD) of Hayward California, a leader in molecular pathology, announced recently the commercial launch of RNAscope® SpotStudio™, a custom-designed image analysis software application for ACD's RNAscope®Assays to detect and quantify RNA biomarkers.

VCAM-1 imaging in ovarian cancer may improve survival

Homing in on vascular cell adhesion molecule-1 (VCAM-1) expression in metastatic ovarian cancer with SPECT could gauge response to therapy and potentially improve survival, according to a study published Sept. 12 in the Journal of Nuclear Medicine.